Scalable Neural Interfaces
Neurological and neuropsychiatric disorders have overwhelming societal and economic impacts. We can build highly targeted, minimally invasive technologies that enable us to interface, at scale, with the human brain to understand and treat these conditions.
Opportunity seeds
Within opportunity spaces, but outside the direct scope of our programmes, ARIA funds opportunity seeds: flexible funding of up to an initial £500k for speculative and ambitious research aligned to the opportunity space.
Explore Jacques' opportunity seed projects
In this portfolio we're funding 8 seeds to advance the field of scalable neural interfaces by exploring novel biological materials and pioneering new methods for interfacing with the nervous system.
See where the opportunity lies – read Jacques' perspective.
UK National Partnership for Neurotechnology
Luke Bashford, Newcastle University
A Silence Switch for Cancer: Targeting Neural-tumour Synapses with Neuromodulation
Jake Stroud, CoherenceNeuro
Adapting Non-Pathogenic Fungal Networks Toward Next-Generation Neural Interfaces
Thomas Paterson, University of Sheffield
Oligodendronics: Engineering Biology for Scalable Neural Interfaces
Christopher Chapman, Queen Mary University of London
Non-Invasive Skilled Movement BCI Using Multimodal GPT Models
Katja Kornysheva, University of Birmingham
MAGNIS: Magnetically Guided Neural Interface System
Pietro Valdastri, University of Leeds
Scalable Neural Interfaces for Systemic Disorders via Gut-Brain Pathway Modulation
Guillaume de Lartigue, Monell Chemical Senses Center
Craniomics: Mapping the Neuro-Bone Interface in Neurodegeneration
Jake P. Taylor-King, Relation